| 12091468 |
Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof |
Peter Kurt Nollert von Specht, Munehisa Yabuki, Sadam Yaseen |
2024-09-17 |
$5,157,000 |
| 12005117 |
Methods for inhibiting fibrosis in a subject in need thereof |
Nigel John Brunskill, Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2024-06-11 |
|
| 11981748 |
Methods for inhibiting angiogenesis in a subject in need thereof |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble, Larry W. Tjoelker |
2024-05-14 |
$2,261,000 |
| 11981749 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2024-05-14 |
$2,261,000 |
| 11896621 |
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2024-02-13 |
$6,119,000 |
| 11883493 |
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders |
W. Jason Cummings, Gregory A. Demopulos, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki |
2024-01-30 |
$2,738,000 |
| 11884742 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Clark E. Tedford, James Brian Parent, Gregory A. Demopulos |
2024-01-30 |
$2,738,000 |
| 11613589 |
Compositions for inhibiting MASP-2 dependent complement activation |
Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2023-03-28 |
$9,118,000 |
| 11525011 |
Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2022-12-13 |
$3,968,000 |
| 11027015 |
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders |
W. Jason Cummings, Gregory A. Demopulos, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki |
2021-06-08 |
$18,254,000 |
| 11013772 |
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2021-05-25 |
$17,119,000 |
| 10870708 |
Methods for inhibiting angiogenesis in a subject in need thereof |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble, Larry W. Tjoelker |
2020-12-22 |
|
| 10745274 |
Nucleic acids encoding antibodies specifically binding to MASP-3 |
W. Jason Cummings, Gregory A. Demopulos, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki |
2020-08-18 |
$20,280,000 |
| 10683367 |
Compositions for inhibiting MASP-2 dependent complement activation |
Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2020-06-16 |
$16,561,000 |
| 10639369 |
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders |
W. Jason Cummings, Gregory A. Demopulos, Larry W. Tjoelker, Christi L. Wood, Munehisa Yabuki |
2020-05-05 |
$17,851,000 |
| 10202465 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2019-02-12 |
$15,800,000 |
| 10059776 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2018-08-28 |
|
| 10047165 |
Compositions for inhibiting MASP-2 dependent complement activation |
Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2018-08-14 |
$20,662,000 |
| 9644035 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2017-05-09 |
$9,559,000 |
| 9475885 |
Compositions for inhibiting MASP-2 dependent complement activation |
Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2016-10-25 |
$5,074,000 |
| 9011860 |
Compositions for inhibiting MASP-2 dependent complement activation |
Wayne R. Gombotz, James Brian Parent, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2015-04-21 |
$16,588,000 |
| 8951522 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Gregory A. Demopulos, Hans-Wilhelm Schwaeble |
2015-02-10 |
$13,492,000 |
| 8840893 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Clark E. Tedford, James Brian Parent, Gregory A. Demopulos |
2014-09-23 |
$7,902,000 |
| 8652477 |
Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Clark E. Tedford, James Brian Parent, Gregory A. Demopulos |
2014-02-18 |
$9,463,000 |